Life Sciences

Biden backs covid-19 IP waiver in historic US policy shift

Landmark move suggests realignment in America’s domestic and international healthcare IP stance

Biden backs covid-19 IP waiver in historic US policy shift
Australian patent applications tumble with both locals and foreign filers cutting back
6 May 2021

Australian patent applications tumble with both locals and foreign filers cutting back

Chinese and Indian entities, however, scramble to obtain innovation patents before the second-tier system meets its end in June

Brazilian Senate passes compulsory covid-19 know-how licensing bill
4 May 2021

Brazilian Senate passes compulsory covid-19 know-how licensing bill

Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress

Latest

View all
29 Apr 2021

Hatch-Waxman litigation defendants get taxation boost

A ruling handed down by the US Tax Court this week suggests generics can deduct legal fees for ANDA litigation Read more

27 Apr 2021

SCOTUS setback won’t end FTC’s focus on pharma patent strategies

In AMG Capital Management v FTC, the Supreme Court stripped the Federal Trade Commission of its ability to seek monetary relief for patent-related antitrust infractions. Read more

26 Apr 2021

Get smarter about covid patents or pay the price

On World IP Day it's time to get a few things straight about where the real problems in getting jabs to those who need them really lie Read more

24 Apr 2021

Why high-tech patent expertise will be increasingly valued by life sciences companies

If the experience of NantWorks’ IP chief Mark Kokes is anything to go by, leading strategists from other sectors can make a splash in pharma and biotech Read more

News

View all
15 Feb 2021

Uptrend in oppositions could spell costly delays for Indian patent applicants

Practitioners say greater attention to detail during the prosecution process can head off frivolous challenges Read more

18 Dec 2020

Japan’s leading corporate IP departments revealed

The country's Asia IP Elite made some big strategic shifts in 2020 as they weathered an unprecedented year Read more

17 Dec 2020

China’s top in-house IP teams revealed

In a year marked by resilience, Chinese IP giants are pushing to close the gap with overseas competitors Read more

14 Dec 2020

The Asia IP Elite – a shared commitment to excellence across very different markets

IAM reveals the top in-house IP teams from India, Southeast Asia and Australasia Read more

Analysis

View all
22 Apr 2021

SCOTUS looks likely to limit the assignor estoppel doctrine

Yesterday’s hearing in Minerva Surgical v Hologic is likely to have big implications for transactions and assignee-assignor disputes Read more

21 Apr 2021

The Internet of Bodies could save many lives but risks failing without standards

The long read: Ericsson’s Eleftheria Stefanaki raises the alarm over a lack of data security and rising interoperability issues, which could fatally damage personal health innovations unless standards-setting organisations get organised – and fast. Read more

20 Apr 2021

TRIPS covid vaccine IP waiver proposal fails to address crucial questions

President Biden and other leaders are coming under pressure to agree a suspension of IP rights, but a key point has been missed Read more

15 Apr 2021

Korean Supreme Court tears up tough inventiveness standard

Life sciences innovators set to benefit from landmark Eliquis decision Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more